This is the authors' abstract. We don't add key points for this paper.
Ewing's sarcoma family tumors (ESFT) are characterized by specific chromosomal translocations, which give rise to EWS-ETS chimeric proteins. These aberrant transcription factors are the main pathogenic drivers of ESFT. Elucidation of the factors influencing EWS-ETS expression and/or activity will guide the development of novel therapeutic agents against this fatal disease.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Herrero‐Martín et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: